#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Belgium France Germany Greece Hungary +8

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Belgium France Germany Italy Spain

  • Study on the Effectiveness of Floxuridine and Drug Combination for Patients with Unresectable Colorectal Liver Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study Comparing Trifluridine/Tipiracil with Panitumumab or Bevacizumab for Patients with Metastatic Colorectal Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of petosemtamab alone or with drug combination for patients with advanced colorectal cancer and other solid tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +5

  • Study of immune response and biomarkers in patients with metastatic solid tumors treated with BMS-986340 and nivolumab

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Postoperative oxaliplatin liver‑directed chemotherapy plus drug combination in patients with resected colorectal liver metastases at high risk of recurrence

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Testing continuous versus intermittent treatment with cetuximab, fluorouracil, folinic acid, and irinotecan in patients with newly diagnosed metastatic colorectal cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Germany

  • Study on the Effects of Different Dosing Schedules of Irinotecan Hydrochloride, Calcium Folinate, and Fluorouracil in Patients with Metastatic Colorectal Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Hungary